Default image

BullDigest's May 8 Post-Market Summary of Super Micro Computer, Inc.

  • 08.05.2025 22:08
  • bulldigest.com
  • Keywords: Post-Market, Summary, Super Micro Computer, Inc.

Check out BullDigest's May 8 Post-Market Summary of Super Micro Computer, Inc.. We provide a summary of the key news from market opening hours.

Post-Market Summary

Estimated market influence

Predictive Oncology Inc.

Positivesentiment_satisfied
Analyst rating: N/A

The company's stock price has shown fluctuations with a decrease in after-hours trading.

Helomics

Positivesentiment_satisfied
Analyst rating: N/A

Provides AI contract services and partners on projects, contributing to the company's operations.

zPREDICTA

Positivesentiment_satisfied
Analyst rating: N/A

Focuses on 3D disease models for drug testing, enhancing research capabilities.

Skyline

Positivesentiment_satisfied
Analyst rating: N/A

Handles sales of the STREAMWAY System and manages TumorGenesis subsidiary.

Soluble

Positivesentiment_satisfied
Analyst rating: N/A

Develops automated self-interaction chromatography for protein formulations, aiding in drug development processes.

Context

Business Insights and Market Implications Summary

Stock Performance

  • Current Price (After Hours): $1.0200 (-4.67%)
  • Previous Close: $1.0700 (+5.94%)
  • Volume: 10 shares after hours, significantly below the 65-day average of 2.69M.
  • Performance Metrics:
    • 5 Day: -8.55%
    • 1 Month: +9.90%
    • 3 Month: -30.07%
    • YTD: +30.49%
    • 1 Year: -39.20%

Financial Health

  • Market Cap: $9.02M
  • Shares Outstanding: 8.93M
  • Public Float: 8.8M
  • Short Interest: 266.98K (3.03% of float)
  • Beta: 1.17

Company Overview and Operations

  • Segments:
    • Helomics: AI contract services, partnerships, clinical testing.
    • zPREDICTA: 3D disease models for drug testing.
    • Skyline: STREAMWAY System sales, TumorGenesis subsidiary.
    • Soluble: Automated self-interaction chromatography for protein formulations.
  • Revenue per Employee: $67.66K
  • EPS: -$2.5296

Market Context

  • Indices Performance:
    • Dow Jones Industrial Average: +0.62%
    • Apple Inc.: +0.63%
    • Microsoft Corp.: +1.11%
    • Alphabet Inc. Cl A: +1.92%

Competitive Landscape and Strategic Considerations

  • Analyst Rating: 1 Buy.
  • Potential Risks and Opportunities:
    • Volatility due to high short interest and low trading volume.
    • Small market cap and limited analyst coverage suggest higher risk for investors.
    • Long-term implications include challenges in attracting investment, potential M&A activity, and regulatory scrutiny typical for AI-driven healthcare companies.

Conclusion

POAI's stock is underperforming despite broader market positivity. High short interest and low trading volume indicate investor uncertainty. The company faces risks associated with its small size and limited analyst coverage, which could impact long-term viability and strategic direction.